RapID Portable Raman Raw Material ID Verification from Agilent Technologies

Get Quote

Get Quote from
Agilent Technologies for
RapID Portable Raman Raw Material ID Verification

Description

The RapID Raman system is the fastest solution for raw material testing in pharmaceutical GMP quality control. RapID is a flexible, mobile, probe-based scanner that uses Agilent spatially offset Raman spectroscopy (SORS) technology to extend high-throughput spectroscopic analysis through clear packaging to nontransparent and colored containers. This unique capability makes RapID ideally suited to fast, nonintrusive raw material identity verification.

With conventional techniques, raw material testing in opaque containers can create a bottleneck in pharmaceutical manufacturing. A dedicated sampling area is needed to open, sample, test, and reseal each container to verify the identity of the contents. The RapID system allows the operator to verify the contents of each container through opaque and colored packaging in seconds, enabling release immediately into production. This saving on handling and lab testing reduces the overhead from hours or days to only minutes per batch.

Features
  • Expand your capabilities: mobile Raman ID through opaque and transparent containers.
  • Accelerate workflows: the fastest ID workflow and 100% ID testing for all incoming containers.
  • Simplify processes: avoid time-consuming sampling procedures and optimize raw material quality.
  • Reduce risks: maintain sterility, prevent cross-contamination, and eliminate operator exposure through non-invasive analysis. Streamline sterile manufacturing of parenteral and biological products.
  • Adapt with versatility: compatible with most APIs, excipients, and containers—like multilayer paper and plastic sacks, opaque plastic drums, and thick amber glass bottles. Optional accessories are available for rapid analysis.
  • Meet data integrity standards: built-in technical controls ensure the security of your data, control access, and facilitate compliance as defined by US FDA 21 CFR Part 11, EU Annex 11, and similar national electronic record regulations.